MARKET REPORT: All smiles as ITV hit 15-year high
ITV brightened 9¼p to a 15-year high at 270½p as Morgan Stanley upped its price target on the broadcaster's shares to 300p.
Shire improved 260p to 5680p after the US Food & Drug Administration granted a priority review to its application for dry-eye disease treatment Lifitegrast.
Fellow drugs giant AstraZeneca fell 11½p to 4753p after a review of data by the FDA found its diabetes drug Onglyza may be linked with an increased death rate.
Nearly £19billion was added to the value of Britain's blue chips as the FTSE 100 hit a record high 7089.77, up 74.41 points.
Upbeat broker Jefferies underpinned housebuilding, where Taylor Wimpey and Barratt Developments added 5p to 166p and 17p to 558p, but a SocGen downgrade from hold to sell hit B&Q operator Kingfisher, 3p off at 364p.
Poundland lost 14½p to 330p amid concerns over its £55million takeover of discount rival 99p Stores after regulators said they will examine the deal.
Blur Group, an online marketplace for business services, plunged 23½p to 57½p as it warned of substantially lower revenues.
